Neuroimaging reveals the stark truth - in FTD, the frontal and temporal lobes literally shrink. MRI scans show cortical thinning, enlarged ventricles, widened sulci, and dramatic volume loss in these regions. These areas govern our highest human functions: judgment, empathy, language, impulse control, and planning.
The pathological process involves abnormal accumulation of specific proteins (tau or TDP-43) in neurons, leading to cell death. Unlike Alzheimer's where memory-forming hippocampus is hit first, FTD targets the social and language networks. PET scans demonstrate reduced metabolic activity in frontal and temporal lobes, creating a distinctive pattern that helps differentiate FTD from Alzheimer's.
Genetic factors play significant roles. Researchers have identified over 500 mutations associated with similar conditions, such as the L160P mutation in the ABCD1 gene found in one 37-year-old patient who developed frontal lobe dementia symptoms along with spastic quadriparesis. About 40% of FTD cases have family history, suggesting strong hereditary components.